摘要:
The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
摘要:
The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
摘要:
The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
摘要:
The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
摘要:
The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
摘要:
The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
摘要:
The present invention relates to amide compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing these compounds and to their use in therapy.
摘要:
The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
摘要:
The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
摘要:
A device for opening a passenger door of an aircraft includes a supporting arm connected movably to the fuselage frame, a wishbone connecting the support arm to the passenger door, a first journal rotatably connecting the wishbone to the support arm, and a lifting mechanism. The lifting mechanism includes a lifting shaft for raising and lowering the door, a lowering safety shaft, a controllable drive engaged with the lowering safety shaft to rotate lowering safety shaft, and a lowering safety link. The lifting shaft includes two ends and a roller lever disposed at each end, wherein when the passage door is in the closed position, each roller lever engages a fuselage frame mounting. The lowering safety shaft includes an end and a roller lever disposed at the end. The lowering safety shaft is engaged with the lifting shaft. The lowering safety link includes a second journal having an elongated configuration. The second journal has a link track, and the roller of the lowering safety shaft is guided on the link track of the second journal.